Longevity Industry 2022 Journal
Longevity Industry 2022 Journal is designed to serve as the first dedicated industry journal for the exponentially expanding Global Longevity Industry, and the first in a series of journals updated and released every financial quarter.
The Journal presents up-to-date summaries, investment and sector-specific digests, key market trends and near-future forecasts of the full scope of Longevity Industry developments as of Q1 2022, compressed into quickly understandable summaries and chapters in order to distil only the most important take-aways required for investors, entrepreneurs, medical professionals and practitioners, policy makers, financial executives and other Longevity Industry professionals to optimize their decision making, effectively plan their near-future strategic agendas for 2022 and beyond, and obtain tangible and reliable state-of-the-market intelligence and digests on the continued, multifaceted evolution of the global megatrend of Longevity Industrialization.
Longevity Industry in 2022
50 000+ companies
10 000+
investors
1 000+
R&D centres
35 000+
clinical trials
Longevity Industry 2022 Journal reflects a maximally objective and unbiased digest of:
-
The current state of the Longevity Industry
-
The main challenges and opportunities for all market players
-
The near-future of Longevity Industry subsectores and domains
Tackle the challenges of Longevity Industry using our insights:
-
Explore Longevity Industry Trends
-
Discover M&As and Biomarker Companies Distribution
-
Learn about the industry framework – Longevity science, Longevity medicine, Longevity financials and AgeTech
-
Examine the data to help you remain positioned at the top
Global Longevity Ecosystem
Latest Longevity Analytical Reports
.png)
Regenerative Medicine Landscape Overview
Regenerative Medicine Q1 2022 gives comprehensive overview of the global market of Regenerative Medicine for control of human longevity and reparation, replacement, and regeneration of tissues and organs affected by injury, disease, or natural aging process. All the technologies described in the analytical case study are already in use, available, and ready for further research.
Production Counterparties
.png)
Deep Knowledge Group is a consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, FinTech, GovTech, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, media, philanthropy and more.
.png)
Aging Analytics Agency is the world’s premier provider of industry analytics on the topics of Longevity, Precision Preventive Medicine and Economics of Aging, and the convergence of technologies such as AI, Blockchain, Digital Health and their impact on the healthcare industry. The company provides strategic consulting services in fields relating to Longevity, and currently serves as the primary source of analytics and data for the UK All-Party Parliamentary Group for Longevity.
Longevity.International is a first-of-its-kind, open-access non-profit decentralized Longevity Industry Knowledge and Collaboration platform with the aim of promoting a greater degree of synergy, efficient cooperation, and discussion among a variety of Longevity Industry participants and stakeholders.
Full Video
